HNRNPH1 (Heterogeneous Nuclear Ribonucleoprotein H1) is a gene located on chromosome 5q31.3 that encodes an RNA-binding protein involved in various aspects of RNA processing, including alternative splicing, RNA stability, and translation regulation. This protein is a member of the hnRNP H family, characterized by quasi-RRM (RNA recognition motif) domains that confer specific RNA binding properties.
**HNRNPH1 Quick Facts**
Property
Value
Gene Symbol
HNRNPH1
Full Name
Heterogeneous Nuclear Ribonucleoprotein H1
Chromosome
5q31.3
NCBI Gene ID
3067
UniProt ID
P31946
Ensembl ID
ENSG00000135638
Aliases
HNRPH1, HPRH1, HNRPH
Protein Length
449 aa
Primary Function
RNA processing, alternative splicing, stress granule formation
Associated Diseases
ALS, FTD, Alzheimer's disease, tauopathy
¶ Gene Structure and Expression
The HNRNPH1 gene consists of 10 exons and encodes a protein of 449 amino acids. The gene produces multiple alternatively spliced isoforms with tissue-specific expression patterns.
HNRNPH1 is ubiquitously expressed with particularly high levels in:
Brain : Cerebral cortex , hippocampus , cerebellum, spinal cord
Muscle : Skeletal muscle, cardiac muscle
Liver : Hepatocytes
Kidney : Renal tubular cells
Within the nervous system, HNRNPH1 is expressed in both neurons and glial cells. Its expression is particularly high in motor neurons, which are selectively vulnerable in ALS.
Nucleus : Primary localization; concentrated in splicing speckles
Cytoplasm : Dynamic distribution, especially to stress granules
Neuronal processes : Detected in axons and dendrites
Synapses : Present at synaptic terminals
¶ Protein Domains and Function
¶ Domain Architecture
HNRNPH1 contains several functional domains:
Quasi-RRM1 (N-terminal) : First RNA recognition motif, N-terminal extension enhances specificity
Quasi-RRM2 (C-terminal) : Second RRM with unique features
Glycine-rich region : Mediates protein-protein interactions
Phosphorylation sites : Regulatory post-translational modifications
The quasi-RRM domains of HNRNPH1 confer distinctive RNA binding properties:
G-rich RNA recognition : Preferential binding to guanine-rich sequences
Branch point binding : Recognition of pre-mRNA branch point sequences
Splice site selection : Influences selection of alternative splice sites
HNRNPH1 plays critical roles in regulating alternative splicing:
MAPT exon 10 : HNRNPH1 regulates the splicing of tau exon 10, affecting the 3R/4R tau ratio
Neural-specific exons : Controls inclusion of neuron-specific exons
FLNA exon : Regulates filamin A alternative splicing
HNRNPH1 affects mRNA stability through:
AU-rich elements : Binding to AREs in 3' UTRs
mRNA decay regulation : Recruiting decay machinery
Translation regulation : Modulating translational efficiency
HNRNPH1 is strongly implicated in ALS pathogenesis through multiple mechanisms:
Stress granule formation : HNRNPH1 rapidly translocates to stress granules under cellular stress
TDP-43 interaction : HNRNPH1 colocalizes with TDP-43 in stress granules
Sequestration by DPRs : C9orf72 dipeptide repeats can sequester HNRNPH1 into toxic granules
Granule dynamics : Abnormal stress granule assembly/disassembly is a hallmark of ALS
High expression : Motor neurons express high levels of HNRNPH1
RNA metabolism burden : Motor neurons have high RNA metabolic demands
Long axons : Requires efficient RNA transport and local translation
Splicing alterations : HNRNPH1-dependent splicing is disrupted in ALS
Target misregulation : Key neuronal transcripts are improperly processed
Aggregate burden : TDP-43 inclusions overwhelm RNA processing capacity
HNRNPH1 contributes to FTD pathophysiology:
TDP-43 pathology : FTD with TDP-43 pathology involves HNRNPH1 dysregulation
Alternative splicing changes : Similar to ALS, splicing is affected
Stress granule abnormalities : Common mechanism with ALS
HNRNPH1 plays important roles in AD through tau metabolism:
3R/4R balance : HNRNPH1 regulates MAPT exon 10 inclusion
Balance disruption : Abnormal 3R/4R ratio is a feature of AD
Therapeutic target : Modulating HNRNPH1 could restore tau splicing
RNA processing impairment : Amyloid-β oligomers disrupt HNRNPH1 function
Synaptic dysfunction : HNRNPH1 at synapses is affected by amyloid
Compensatory changes : HNRNPH1 expression may be upregulated as compensation
Tau aggregation : HNRNPH1 interactions with tau affect pathology
Phosphorylation effects : Tau phosphorylation alters HNRNPH1 binding
Protein/Pathway
Interaction
Functional Consequence
TDP-43
Stress granule colocalization
RNA processing regulation
MAPT
Exon 10 splicing regulation
Tau isoform balance
FUS
Stress granule interaction
RNA granule dynamics
C9orf72
DPR sequestration
Toxic gain-of-function
hnRNPA1
Paralog cooperation
Splicing regulation
TIA1
Stress granule component
Granule formation
Stress Granule Modulators
Compounds that normalize stress granule dynamics
Inhibitors of pathological granule assembly
Splicing Modulators
ASOs targeting HNRNPH1-regulated exons
Small molecules that modulate splicing factors
Protein-Protein Interaction Inhibitors
Disrupt pathological HNRNPH1 interactions
Prevent DPR sequestration
Antisense oligonucleotides : Modulate HNRNPH1 expression or splicing
RNA-binding small molecules : Alter HNRNPH1-RNA interactions
Granule disassembly promoters : Enhance clearance of pathological granules
Inflammation modulators : Reduce stress that triggers granule formation
RNA metabolism support : Enhance overall RNA processing capacity
Synaptic protection : Preserve HNRNPH1 at synapses
Cell lines : NSC34 (motor neuron), SH-SY5Y (neuronal), HEK293
Animal models : Transgenic hnrnph1 mice, TDP-43 models
iPSC models : Motor neurons from ALS patients
¶ Antibodies and Reagents
Anti-HNRNPH1: Abcam (ab154574), Sigma (HPA044456)
Stress granule markers: G3BP1, TIA1, PABP1
HNRNPH2 — HNRNPH1 paralog, similar functions
TARDBP — TDP-43 encoding gene
C9orf72 — Common ALS/FTD gene
FUS — FUS protein in ALS/FTD
MAPT — Tau encoding gene